HERC2

Last updated

HERC2 is a giant E3 ubiquitin protein ligase, implicated in DNA repair regulation, pigmentation and neurological disorders. It is encoded by a gene of the same name belonging to the HERC family, which typically encodes large protein products with C-terminal HECT domains and one or more RCC1-like (RLD) domains. [1] [2]

Contents

History

HERC2, previously referred to as the rjs gene locus, was first identified in 1990 as the gene responsible for two phenotypes in mice: the runty, jerky, sterile (rjs) phenotype and the juvenile development and fertility-2 (Jdf2) phenotype. Mutant alleles are known to cause hypo-pigmentation and pink eye phenotypes, as well reduced growth, jerky gait, male sterility, female semi-sterility, and maternal behaviour defects in mice. [3] [4] [5]

Gene locus

The full HERC2 gene is located at 15q13, encoded by 93 exons and its transcription is under the control of a CpG rich promoter. This region on chromosome 15 is susceptible to breaks during chromosomal rearrangement and there are at least 12 partial duplicates of HERC2 between 15q11–15q13. [6]

At least 15 HERC2 SNPs have been identified and they are strongly associated with human iris colour variability, functioning to repress expression of OCA2's product. [7]

Protein structure

HERC2 encodes a 4834-amino acid protein with a theoretical size of 528 kDa. While a full structure has not yet been elucidated, potentially due to its large size, partial structures of its domains have been captured. [8]

It has an N-terminal bilobed HECT domain, conferring E3 ligase functionality, as well as 3 RLD domains with seven-bladed β-propeller folds. In addition to these HERC family hallmarks, it has several other motifs; a cytochrome-b5-like domain, several potential phosphorylation sites, and a ZZ-type zinc finger motif. [1] This is likely involved in protein binding, and has recently been identified as a SUMOylation target following DNA damage. [9]

Expression of HERC2 is ubiquitous, though particularly high in the brain and testes. Cellular localisation is predominantly to the nucleus and cytoplasm. [1]

The third RLD domain of HERC2, captured at 1.8 A by X-ray diffraction (3KCI) 3KCI The third RLD domain of HERC2.jpg
The third RLD domain of HERC2, captured at 1.8 Å by X-ray diffraction (3KCI)
The cytochrome-b5-like domain of HERC2, captured with NMR spectroscopy (2KEO) 2KEO cytochrome-b5-like domain.jpg
The cytochrome-b5-like domain of HERC2, captured with NMR spectroscopy (2KEO)
The first RLD domain of HERC2, captured at 2.6 A by X-ray diffraction (4L1M) 4L1M Structure of the first RCC1-like domain of HERC2.jpg
The first RLD domain of HERC2, captured at 2.6 Å by X-ray diffraction (4L1M)

Protein function

Pigmentation

SNPs of HERC2 are strongly associated with iris colour variability in humans. In particular, the rs916977 and rs12913832 SNPs have been reported as good predictors of this trait, and the latter is also significantly associated with skin and hair colour. The ancestral allele is linked to darker pigmentation and dominant over the lighter pigment recessive allele. [10] [11] The rs12913832 SNP, located in intron 86 of the HERC2 gene contains a silencing sequence that can inhibit the expression of OCA2 and, if both recessive alleles are present, can homozygously cause blue eyes. [12] This genotype is present in almost all people with blue eyes and is hypothesised as being the founder mutation of blue eyes in humans. [13] [14] [15]

The rs916977 SNP is most common in Europe; particularly in the north and east, where it nears fixation. The variant is also found at high frequencies in North Africa, the Near East, Oceania and the Americas. [16]

DNA repair pathways

HERC2 is a component of the replication fork and essential for DNA damage repair pathways. Regulating DNA repair pathways is necessary, as unchecked they can target and excise undamaged DNA, potentially leading to mutation. [17]

It is involved in coordinating the Chk1-directed DNA damage/cell cycle checkpoint response by regulating the stability of the deubiquitination enzyme USP20. Under normal conditions HERC2 associates with USP20 and ubiquitinates it for degradation. Under replication stress, for example a DNA polymerase mismatch error, USP20 disassociates from HERC2 and deubiquitinates claspin, stabilising it to then bind and activate Chk1. This allows for DNA replication to be paused and the error corrected. [18] [19] [20]

At the site of doubles stranded breaks, HERC2 facilitates the binding of RNF8, a RING finger ubiquitin ligase to the E2 ubiquitin-conjugating enzyme UBC13. This association is required for RNF8 mediated Lys-63 poly-ubiquitination signalling, which both recruits and retains repair factors at the site of DNA damage to commence homologous recombination repair. [21]

HERC2 is also involved in regulating nucleotide excision repair by ubiquitinating the XPA repair protein for proteolysis. XPA is involved in recognising DNA damage and provides a scaffold for other repair factors to bind at the damage site. [22] [23]

Centrosome assembly

HERC2 has been implicated in regulating stable centrosome architecture in conjunction with NEURL4 other ubiquitinated binding partners. Its absence is associated with aberrant centrosome morphology. [24]

Iron metabolism

HERC2 has recently been associated with regulating iron metabolism through ubiquitinating the F-box and leucine-rich repeat protein 5 (FBXL5) for proteasomal degradation. FBXL5 regulates the stability of the iron regulatory protein (IR2), which in turn controls the stability of proteins overlooking cellular iron homeostasis. Depletion of HERC2 results in decreased cellular iron levels. Iron is an essential nutrient in cells, but high levels can be cytotoxic, so maintaining cellular levels is important. [25]

Other functions

HERC2 helps to regulate p53 signalling by facilitating the oligomerization of p53, which is necessary for its transcriptional activity. Silencing of HERC2 reportedly inhibits the expression of genes regulated by p53 and also results in increased cellular growth. [26]

Clinical significance

The 15q11-q13 locus of HERC2 is also associated with Angelman syndrome (AS), specifically when a region of this locus is deleted. Similar to the rjs phenotype attributed to HERC2 in mice, AS is associated with seizures, developmental delay, intellectual disability and jerky movements. While a variety of disturbances to this locus can cause AS, all known mechanisms affect the functioning and expression of the E6AP E3 ligase, which also sits at this locus. HER2 is an allosteric activator of E6AP, and lies at the most commonly deleted region in AS. [27] Its deletion could result in the inactivation of E6AP and consequently the development of AS. [28]

In Old Order Amish families, a homozygous proline to leucine missense mutation within the first RLD domain has been implicated in a neurodevelopmental disorder with autism and features resembling AS. [29] In addition, a homozygous deletion of both OCA2 and HERC2 genes was recently reported as presenting with severe developmental abnormalities. [30] These phenotypes are suggestive of a role for HERC2 in normal neurodevelopment.

Certain alleles of HERC2 has recently been implicated in increasing the risk of iris cancer. Due its role in pigment determination, three HERC2 SNPs have been highlighted as associated with uveal melanoma. [31] HERC2 frameshift mutations have also been described in colorectal cancers. [32]

In accordance to its role in facilitating p53 oligomerization, HERC2 may be causally related to Li-Fraumeni syndrome and Li-Fraumeni-like syndromes, which occur in the absence of sufficient p53 oligomerization. [26]

Interactions

HERC2 is known to interact with the following:

Evolution

The HERC2 variation for blue eyes first appears around 14,000 years ago in Italy and the Caucasus. [35]

See also

Related Research Articles

p53 Mammalian protein found in humans

p53, also known as Tumor protein P53, cellular tumor antigen p53, or transformation-related protein 53 (TRP53) is a regulatory protein that is often mutated in human cancers. The p53 proteins are crucial in vertebrates, where they prevent cancer formation. As such, p53 has been described as "the guardian of the genome" because of its role in conserving stability by preventing genome mutation. Hence TP53 is classified as a tumor suppressor gene.

<span class="mw-page-title-main">Ubiquitin</span> Regulatory protein found in most eukaryotic tissues

Ubiquitin is a small (8.6 kDa) regulatory protein found in most tissues of eukaryotic organisms, i.e., it is found ubiquitously. It was discovered in 1975 by Gideon Goldstein and further characterized throughout the late 1970s and 1980s. Four genes in the human genome code for ubiquitin: UBB, UBC, UBA52 and RPS27A.

<span class="mw-page-title-main">Ubiquitin ligase</span> Protein

A ubiquitin ligase is a protein that recruits an E2 ubiquitin-conjugating enzyme that has been loaded with ubiquitin, recognizes a protein substrate, and assists or directly catalyzes the transfer of ubiquitin from the E2 to the protein substrate. In simple and more general terms, the ligase enables movement of ubiquitin from a ubiquitin carrier to another protein by some mechanism. The ubiquitin, once it reaches its destination, ends up being attached by an isopeptide bond to a lysine residue, which is part of the target protein. E3 ligases interact with both the target protein and the E2 enzyme, and so impart substrate specificity to the E2. Commonly, E3s polyubiquitinate their substrate with Lys48-linked chains of ubiquitin, targeting the substrate for destruction by the proteasome. However, many other types of linkages are possible and alter a protein's activity, interactions, or localization. Ubiquitination by E3 ligases regulates diverse areas such as cell trafficking, DNA repair, and signaling and is of profound importance in cell biology. E3 ligases are also key players in cell cycle control, mediating the degradation of cyclins, as well as cyclin dependent kinase inhibitor proteins. The human genome encodes over 600 putative E3 ligases, allowing for tremendous diversity in substrates.

<span class="mw-page-title-main">Parkin (protein)</span>

Parkin is a 465-amino acid residue E3 ubiquitin ligase, a protein that in humans and mice is encoded by the PARK2 gene. Parkin plays a critical role in ubiquitination – the process whereby molecules are covalently labelled with ubiquitin (Ub) and directed towards degradation in proteasomes or lysosomes. Ubiquitination involves the sequential action of three enzymes. First, an E1 ubiquitin-activating enzyme binds to inactive Ub in eukaryotic cells via a thioester bond and mobilises it in an ATP-dependent process. Ub is then transferred to an E2 ubiquitin-conjugating enzyme before being conjugated to the target protein via an E3 ubiquitin ligase. There exists a multitude of E3 ligases, which differ in structure and substrate specificity to allow selective targeting of proteins to intracellular degradation.

<span class="mw-page-title-main">Nucleotide excision repair</span> DNA repair mechanism

Nucleotide excision repair is a DNA repair mechanism. DNA damage occurs constantly because of chemicals, radiation and other mutagens. Three excision repair pathways exist to repair single stranded DNA damage: Nucleotide excision repair (NER), base excision repair (BER), and DNA mismatch repair (MMR). While the BER pathway can recognize specific non-bulky lesions in DNA, it can correct only damaged bases that are removed by specific glycosylases. Similarly, the MMR pathway only targets mismatched Watson-Crick base pairs.

<span class="mw-page-title-main">UBE3A</span> Protein-coding gene in Homo sapiens

Ubiquitin-protein ligase E3A (UBE3A) also known as E6AP ubiquitin-protein ligase (E6AP) is an enzyme that in humans is encoded by the UBE3A gene. This enzyme is involved in targeting proteins for degradation within cells.

<span class="mw-page-title-main">Mdm2</span> Protein-coding gene in humans

Mouse double minute 2 homolog (MDM2) also known as E3 ubiquitin-protein ligase Mdm2 is a protein that in humans is encoded by the MDM2 gene. Mdm2 is an important negative regulator of the p53 tumor suppressor. Mdm2 protein functions both as an E3 ubiquitin ligase that recognizes the N-terminal trans-activation domain (TAD) of the p53 tumor suppressor and as an inhibitor of p53 transcriptional activation.

<span class="mw-page-title-main">Topotecan</span> Chemical compound

Topotecan, sold under the brand name Hycamtin among others, is a chemotherapeutic agent medication that is a topoisomerase inhibitor. It is a synthetic, water-soluble analog of the natural chemical compound camptothecin. It is used in the form of its hydrochloride salt to treat ovarian cancer, lung cancer and other cancer types.

Lethal alleles are alleles that cause the death of the organism that carries them. They are usually a result of mutations in genes that are essential for growth or development. Lethal alleles may be recessive, dominant, or conditional depending on the gene or genes involved.

<span class="mw-page-title-main">DDB2</span> Protein-coding gene in the species Homo sapiens

DNA damage-binding protein 2 is a protein that in humans is encoded by the DDB2 gene.

<span class="mw-page-title-main">DDB1</span> Protein-coding gene in the species Homo sapiens

DNA damage-binding protein 1 is a protein that in humans is encoded by the DDB1 gene.

<span class="mw-page-title-main">TYRP1</span> Enzyme

Tyrosinase-related protein 1, also known as TYRP1, is an intermembrane enzyme which in humans is encoded by the TYRP1 gene.

<span class="mw-page-title-main">P protein</span> Protein-coding gene in humans

P protein, also known as melanocyte-specific transporter protein or pink-eyed dilution protein homolog, is a protein that in humans is encoded by the oculocutaneous albinism II (OCA2) gene. The P protein is believed to be an integral membrane protein involved in small molecule transport, specifically of tyrosine—a precursor of melanin. Certain mutations in OCA2 result in type 2 oculocutaneous albinism. OCA2 encodes the human homologue of the mouse p gene.

<span class="mw-page-title-main">RAD52</span> Protein-coding gene in the species Homo sapiens

RAD52 homolog , also known as RAD52, is a protein which in humans is encoded by the RAD52 gene.

<span class="mw-page-title-main">MDC1</span> Protein-coding gene in the species Homo sapiens

Mediator of DNA damage checkpoint protein 1 is a 2080 amino acid long protein that in humans is encoded by the MDC1 gene located on the short arm (p) of chromosome 6. MDC1 protein is a regulator of the Intra-S phase and the G2/M cell cycle checkpoints and recruits repair proteins to the site of DNA damage. It is involved in determining cell survival fate in association with tumor suppressor protein p53. This protein also goes by the name Nuclear Factor with BRCT Domain 1 (NFBD1).

<span class="mw-page-title-main">UBE2D1</span> Protein-coding gene in the species Homo sapiens

Ubiquitin-conjugating enzyme E2 D1 is a protein that in humans is encoded by the UBE2D1 gene.

<span class="mw-page-title-main">CUL4B</span> Protein-coding gene in humans

Cullin-4B is a protein that in humans is encoded by the CUL4B gene which is located on the X chromosome. CUL4B has high sequence similarity with CUL4A, with which it shares certain E3 ubiquitin ligase functions. CUL4B is largely expressed in the nucleus and regulates several key functions including: cell cycle progression, chromatin remodeling and neurological and placental development in mice. In humans, CUL4B has been implicated in X-linked intellectual disability and is frequently mutated in pancreatic adenocarcinomas and a small percentage of various lung cancers. Viruses such as HIV can also co-opt CUL4B-based complexes to promote viral pathogenesis. CUL4B complexes containing Cereblon are also targeted by the teratogenic drug thalidomide.

<span class="mw-page-title-main">CCNF</span> Protein-coding gene in humans

G2/mitotic-specific cyclin-F is a protein that in humans is encoded by the CCNF gene.

<span class="mw-page-title-main">WRAP53</span> Protein-coding gene in the species Homo sapiens

WRAP53 is a gene implicated in cancer development. The name was coined in 2009 to describe the dual role of this gene, encoding both an antisense RNA that regulates the p53 tumor suppressor and a protein involved in DNA repair, telomere elongation and maintenance of nuclear organelles Cajal bodies.

<span class="mw-page-title-main">Ubiquitin-protein ligase E3B</span> Protein-coding gene in Homo sapiens

Ubiquitin-Protein Ligase E3B (UBE3B) is an enzyme encoded by UBE3B gene in humans. UBE3B has an N-terminal IQ motif, which mediates calcium-independent calmodulin binding and a large C-terminal catalytic HECT domain.

References

  1. 1 2 3 Sánchez-Tena S, Cubillos-Rojas M, Schneider T, Rosa JL (May 2016). "Functional and pathological relevance of HERC family proteins: a decade later". Cellular and Molecular Life Sciences. 73 (10): 1955–68. doi:10.1007/s00018-016-2139-8. PMC   11108380 . PMID   26801221. S2CID   7457614.
  2. ↑ Hochrainer K, Mayer H, Baranyi U, Binder B, Lipp J, Kroismayr R (February 2005). "The human HERC family of ubiquitin ligases: novel members, genomic organization, expression profiling, and evolutionary aspects". Genomics. 85 (2): 153–64. doi:10.1016/j.ygeno.2004.10.006. PMID   15676274.
  3. ↑ Lehman AL, Nakatsu Y, Ching A, Bronson RT, Oakey RJ, Keiper-Hrynko N, Finger JN, Durham-Pierre D, Horton DB, Newton JM, Lyon MF, Brilliant MH (August 1998). "A very large protein with diverse functional motifs is deficient in rjs (runty, jerky, sterile) mice". Proceedings of the National Academy of Sciences of the United States of America. 95 (16): 9436–41. Bibcode:1998PNAS...95.9436L. doi: 10.1073/pnas.95.16.9436 . PMC   21356 . PMID   9689098.
  4. ↑ Ji Y, Walkowicz MJ, Buiting K, Johnson DK, Tarvin RE, Rinchik EM, Horsthemke B, Stubbs L, Nicholls RD (March 1999). "The ancestral gene for transcribed, low-copy repeats in the Prader-Willi/Angelman region encodes a large protein implicated in protein trafficking, which is deficient in mice with neuromuscular and spermiogenic abnormalities". Human Molecular Genetics. 8 (3): 533–42. doi: 10.1093/hmg/8.3.533 . PMID   9949213.
  5. ↑ Brilliant MH (1992). "The mouse pink-eyed dilution locus: a model for aspects of Prader-Willi syndrome, Angelman syndrome, and a form of hypomelanosis of Ito". Mammalian Genome. 3 (4): 187–91. doi:10.1007/bf00355717. PMID   1611213. S2CID   32406842.
  6. ↑ Ji Y, Rebert NA, Joslin JM, Higgins MJ, Schultz RA, Nicholls RD (March 2000). "Structure of the highly conserved HERC2 gene and of multiple partially duplicated paralogs in human". Genome Research. 10 (3): 319–29. doi:10.1101/gr.10.3.319. PMC   311424 . PMID   10720573.
  7. ↑ Kayser M, Liu F, Janssens AC, Rivadeneira F, Lao O, van Duijn K, Vermeulen M, Arp P, Jhamai MM, van Ijcken WF, den Dunnen JT, Heath S, Zelenika D, Despriet DD, Klaver CC, Vingerling JR, de Jong PT, Hofman A, Aulchenko YS, Uitterlinden AG, Oostra BA, van Duijn CM (February 2008). "Three genome-wide association studies and a linkage analysis identify HERC2 as a human iris color gene". American Journal of Human Genetics. 82 (2): 411–23. doi:10.1016/j.ajhg.2007.10.003. PMC   2427174 . PMID   18252221.
  8. ↑ Lemak A, Gutmanas A, Chitayat S, Karra M, Farès C, Sunnerhagen M, Arrowsmith CH (January 2011). "A novel strategy for NMR resonance assignment and protein structure determination". Journal of Biomolecular NMR. 49 (1): 27–38. doi:10.1007/s10858-010-9458-0. PMC   3715383 . PMID   21161328.
  9. ↑ Danielsen JR, Povlsen LK, Villumsen BH, Streicher W, Nilsson J, Wikström M, Bekker-Jensen S, Mailand N (April 2012). "DNA damage-inducible SUMOylation of HERC2 promotes RNF8 binding via a novel SUMO-binding Zinc finger". The Journal of Cell Biology. 197 (2): 179–87. doi:10.1083/jcb.201106152. PMC   3328386 . PMID   22508508.
  10. ↑ Branicki W, Brudnik U, Wojas-Pelc A (March 2009). "Interactions between HERC2, OCA2 and MC1R may influence human pigmentation phenotype". Annals of Human Genetics. 73 (2): 160–70. doi:10.1111/j.1469-1809.2009.00504.x. PMID   19208107. S2CID   5233533.
  11. ↑ Eiberg H, Troelsen J, Nielsen M, Mikkelsen A, Mengel-From J, Kjaer KW, Hansen L (March 2008). "Blue eye color in humans may be caused by a perfectly associated founder mutation in a regulatory element located within the HERC2 gene inhibiting OCA2 expression". Human Genetics. 123 (2): 177–87. doi:10.1007/s00439-007-0460-x. PMID   18172690. S2CID   9886658.
  12. ↑ Sturm RA, Larsson M (October 2009). "Genetics of human iris colour and patterns" (PDF). Pigment Cell & Melanoma Research. 22 (5): 544–62. doi:10.1111/j.1755-148X.2009.00606.x. PMID   19619260. S2CID   893259.
  13. ↑ Bryner J (2008-01-31). "Here's what made those brown eyes blue". Health News. NBC News. Retrieved 2008-11-06.; Bryner J (2008-01-31). "One Common Ancestor Behind Blue Eyes". LiveScience. Imaginova Corp. Retrieved 2008-11-06.; "Blue-eyed humans have a single, common ancestor". News. University of Copenhagen. 2008-01-30. Archived from the original on 2008-11-08. Retrieved 2008-11-06.
  14. ↑ Sturm RA, Duffy DL, Zhao ZZ, Leite FP, Stark MS, Hayward NK, Martin NG, Montgomery GW (February 2008). "A single SNP in an evolutionary conserved region within intron 86 of the HERC2 gene determines human blue-brown eye color". American Journal of Human Genetics. 82 (2): 424–31. doi:10.1016/j.ajhg.2007.11.005. PMC   2427173 . PMID   18252222.
  15. 1 2 Donnelly MP, Paschou P, Grigorenko E, Gurwitz D, Barta C, Lu RB, Zhukova OV, Kim JJ, Siniscalco M, New M, Li H, Kajuna SL, Manolopoulos VG, Speed WC, Pakstis AJ, Kidd JR, Kidd KK (May 2012). "A global view of the OCA2-HERC2 region and pigmentation". Human Genetics. 131 (5): 683–96. doi:10.1007/s00439-011-1110-x. PMC   3325407 . PMID   22065085.
  16. ↑ "Allele Frequency For Polymorphic Site: rs916977". ALFRED. Retrieved 22 June 2016.
  17. ↑ Branum ME, Reardon JT, Sancar A (July 2001). "DNA repair excision nuclease attacks undamaged DNA. A potential source of spontaneous mutations". The Journal of Biological Chemistry. 276 (27): 25421–6. doi: 10.1074/jbc.M101032200 . PMID   11353769.
  18. 1 2 3 Zhu M, Zhao H, Liao J, Xu X (December 2014). "HERC2/USP20 coordinates CHK1 activation by modulating CLASPIN stability". Nucleic Acids Research. 42 (21): 13074–81. doi:10.1093/nar/gku978. PMC   4245974 . PMID   25326330.
  19. 1 2 3 Yuan J, Luo K, Deng M, Li Y, Yin P, Gao B, Fang Y, Wu P, Liu T, Lou Z (December 2014). "HERC2-USP20 axis regulates DNA damage checkpoint through Claspin". Nucleic Acids Research. 42 (21): 13110–21. doi:10.1093/nar/gku1034. PMC   4245938 . PMID   25355518.
  20. 1 2 Izawa N, Wu W, Sato K, Nishikawa H, Kato A, Boku N, Itoh F, Ohta T (September 2011). "HERC2 Interacts with Claspin and regulates DNA origin firing and replication fork progression". Cancer Research. 71 (17): 5621–5. doi: 10.1158/0008-5472.CAN-11-0385 . PMID   21775519.
  21. 1 2 3 4 Bekker-Jensen S, Rendtlew Danielsen J, Fugger K, Gromova I, Nerstedt A, Lukas C, Bartek J, Lukas J, Mailand N (January 2010). "HERC2 coordinates ubiquitin-dependent assembly of DNA repair factors on damaged chromosomes". Nature Cell Biology. 12 (1): 80–6, sup pp 1–12. doi:10.1038/ncb2008. PMID   20023648. S2CID   9996031.
  22. 1 2 Lee TH, Park JM, Leem SH, Kang TH (January 2014). "Coordinated regulation of XPA stability by ATR and HERC2 during nucleotide excision repair". Oncogene. 33 (1): 19–25. doi: 10.1038/onc.2012.539 . PMID   23178497.
  23. 1 2 Kang TH, Lindsey-Boltz LA, Reardon JT, Sancar A (March 2010). "Circadian control of XPA and excision repair of cisplatin-DNA damage by cryptochrome and HERC2 ubiquitin ligase". Proceedings of the National Academy of Sciences of the United States of America. 107 (11): 4890–5. Bibcode:2010PNAS..107.4890K. doi: 10.1073/pnas.0915085107 . PMC   2841896 . PMID   20304803.
  24. 1 2 Al-Hakim AK, Bashkurov M, Gingras AC, Durocher D, Pelletier L (June 2012). "Interaction proteomics identify NEURL4 and the HECT E3 ligase HERC2 as novel modulators of centrosome architecture". Molecular & Cellular Proteomics. 11 (6): M111.014233. doi: 10.1074/mcp.M111.014233 . PMC   3433907 . PMID   22261722.
  25. 1 2 Moroishi T, Yamauchi T, Nishiyama M, Nakayama KI (June 2014). "HERC2 targets the iron regulator FBXL5 for degradation and modulates iron metabolism". The Journal of Biological Chemistry. 289 (23): 16430–41. doi: 10.1074/jbc.M113.541490 . PMC   4047410 . PMID   24778179.
  26. 1 2 3 Cubillos-Rojas M, Amair-Pinedo F, Peiró-Jordán R, Bartrons R, Ventura F, Rosa JL (May 2014). "The E3 ubiquitin protein ligase HERC2 modulates the activity of tumor protein p53 by regulating its oligomerization". The Journal of Biological Chemistry. 289 (21): 14782–95. doi: 10.1074/jbc.M113.527978 . PMC   4031533 . PMID   24722987.
  27. 1 2 Kühnle S, Kogel U, Glockzin S, Marquardt A, Ciechanover A, Matentzoglu K, Scheffner M (June 2011). "Physical and functional interaction of the HECT ubiquitin-protein ligases E6AP and HERC2". The Journal of Biological Chemistry. 286 (22): 19410–6. doi: 10.1074/jbc.M110.205211 . PMC   3103319 . PMID   21493713.
  28. ↑ Harlalka GV, Baple EL, Cross H, Kühnle S, Cubillos-Rojas M, Matentzoglu K, Patton MA, Wagner K, Coblentz R, Ford DL, Mackay DJ, Chioza BA, Scheffner M, Rosa JL, Crosby AH (February 2013). "Mutation of HERC2 causes developmental delay with Angelman-like features" (PDF). Journal of Medical Genetics. 50 (2): 65–73. doi:10.1136/jmedgenet-2012-101367. PMID   23243086. S2CID   206997462.
  29. ↑ Puffenberger EG, Jinks RN, Wang H, Xin B, Fiorentini C, Sherman EA, Degrazio D, Shaw C, Sougnez C, Cibulskis K, Gabriel S, Kelley RI, Morton DH, Strauss KA (December 2012). "A homozygous missense mutation in HERC2 associated with global developmental delay and autism spectrum disorder". Human Mutation. 33 (12): 1639–46. doi: 10.1002/humu.22237 . PMID   23065719. S2CID   10372349.
  30. ↑ Morice-Picard F, Benard G, Rezvani HR, Lasseaux E, Simon D, Moutton S, Rooryck C, Lacombe D, Baumann C, Arveiler B (January 2016). "Complete loss of function of the ubiquitin ligase HERC2 causes a severe neurodevelopmental phenotype". European Journal of Human Genetics. 25 (1): 52–58. doi:10.1038/ejhg.2016.139. PMC   5159772 . PMID   27759030.
  31. ↑ Ferguson R, Vogelsang M, Ucisik-Akkaya E, Rai K, Pilarski R, Martinez CN, Rendleman J, Kazlow E, Nagdimov K, Osman I, Klein RJ, Davidorf FH, Cebulla CM, Abdel-Rahman MH, Kirchhoff T (August 2016). "Genetic markers of pigmentation are novel risk loci for uveal melanoma". Scientific Reports. 6 (1): 31191. Bibcode:2016NatSR...631191F. doi:10.1038/srep31191. PMC   4976361 . PMID   27499155.
  32. ↑ Yoo NJ, Park SW, Lee SH (December 2011). "Frameshift mutations of ubiquitination-related genes HERC2, HERC3, TRIP12, UBE2Q1 and UBE4B in gastric and colorectal carcinomas with microsatellite instability". Pathology. 43 (7): 753–5. doi:10.1097/pat.0b013e32834c7e78. PMID   22124266.
  33. ↑ Wu W, Sato K, Koike A, Nishikawa H, Koizumi H, Venkitaraman AR, Ohta T (August 2010). "HERC2 is an E3 ligase that targets BRCA1 for degradation". Cancer Research. 70 (15): 6384–92. doi: 10.1158/0008-5472.CAN-10-1304 . PMID   20631078.
  34. ↑ Imai Y, Kobayashi Y, Inoshita T, Meng H, Arano T, Uemura K, Asano T, Yoshimi K, Zhang CL, Matsumoto G, Ohtsuka T, Kageyama R, Kiyonari H, Shioi G, Nukina N, Hattori N, Takahashi R (September 2015). "The Parkinson's Disease-Associated Protein Kinase LRRK2 Modulates Notch Signaling through the Endosomal Pathway". PLOS Genetics. 11 (9): e1005503. doi: 10.1371/journal.pgen.1005503 . PMC   4565672 . PMID   26355680.
  35. ↑ Fu Q, Posth C (May 2, 2016). "The genetic history of Ice Age Europe". Nature . 534 (7606): 200–205. Bibcode:2016Natur.534..200F. doi:10.1038/nature17993. hdl:10211.3/198594. PMC   4943878 . PMID   27135931.

Further reading

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.